Kensey Nash (KNSY) Receives 501(k) Clearance from U.S. FDA for Meso BioMatrix Product

May 26, 2010 11:00 AM EDT Send to a Friend
Kensey Nash Corporation (Nasdaq: KNSY) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login